glp-1 for rheumatoid arthritis Receptor Agonists May Improve Symptoms Glucagon-like peptide-1 receptor agonists in
Description
When someone is using a GLP-1 medication, appetite decreases, digestion slows, and food intake often drops
A clinical trial suggests Wegovy, an obesity treatment, may reduce COVID-19 mortality by 33% and lower overall death rates
Here, the authors review the physiological roles of GLP-1, the potential renoprotective mechanisms of incretin-based therapies and the available renal outcome data from clinical trials.
Use CANVA to Repurpose the Templates For Various Uses
